Fatty Liver Disease Global Clinical Trials Review, H2, 2011

GlobalData, September 2011, Pages: 86

Fatty Liver Disease Global Clinical Trials Review, H2, 2011

Summary

GlobalData's clinical trial report, “Fatty Liver Disease Global Clinical Trials Review, H2, 2011" provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fatty Liver Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables
List of Figures
Introduction
Fatty Liver Disease
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Fatty Liver Disease
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Fatty Liver Disease Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Galmed International Ltd.
Clinical Trial Overview of Galmed International Ltd.
Sanofi
Clinical Trial Overview of Sanofi
PharmaKing Co., Ltd.
Clinical Trial Overview of PharmaKing Co., Ltd.
VSL Pharmaceuticals, Inc.
Clinical Trial Overview of VSL Pharmaceuticals, Inc.
Norgine B.V
Clinical Trial Overview of Norgine B.V
CD Pharma India Private Ltd.
Clinical Trial Overview of CD Pharma India Private Ltd.
Intercept Pharmaceuticals, Inc.
Clinical Trial Overview of Intercept Pharmaceuticals, Inc.
Antipodean Pharmaceuticals, Inc.
Clinical Trial Overview of Antipodean Pharmaceuticals, Inc.
GW Pharmaceuticals plc
Clinical Trial Overview of GW Pharmaceuticals plc
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The National Institute of Diabetes and Digestive and Kidney Diseases
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
Ziv Medical Center
Clinical Trial Overview of Ziv Medical Center
Chinese University of Hong Kong
Clinical Trial Overview of Chinese University of Hong Kong
Hadassah Medical Organization
Clinical Trial Overview of Hadassah Medical Organization
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
Osaka City University
Clinical Trial Overview of Osaka City University
University of California, San Diego
Clinical Trial Overview of University of California, San Diego
Duke University
Clinical Trial Overview of Duke University
Assaf-Harofeh Medical Center
Clinical Trial Overview of Assaf-Harofeh Medical Center
Tel-Aviv Sourasky Medical Center
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
University Health Network
Clinical Trial Overview of University Health Network
Columbia University
Clinical Trial Overview of Columbia University
University of Zurich
Clinical Trial Overview of University of Zurich
Brooke Army Medical Center
Clinical Trial Overview of Brooke Army Medical Center
University of Lausanne
Clinical Trial Overview of University of Lausanne
Mayo Clinic
Clinical Trial Overview of Mayo Clinic
Kanazawa University Graduate School of Medicine
Clinical Trial Overview of Kanazawa University Graduate School of Medicine
Aristotle University Of Thessaloniki
Clinical Trial Overview of Aristotle University Of Thessaloniki
The Hospital for Sick Children
Clinical Trial Overview of The Hospital for Sick Children
University of Michigan
Clinical Trial Overview of University of Michigan
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Zone, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, BRIC Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, G7 Countries, 2011-
Fatty Liver Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, E7 Countries, 2011-
Fatty Liver Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Phase, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Fatty Liver Disease Therapeutics Market, Global, Terminated Clinical Trials, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by PharmaKing Co., Ltd., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by VSL Pharmaceuticals, Inc., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Norgine B.V, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by CD Pharma India Private Ltd., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Intercept Pharmaceuticals, Inc., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Antipodean Pharmaceuticals, Inc., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals plc, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ziv Medical Center, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka City University, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Brooke Army Medical Center, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Lausanne, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa University Graduate School of Medicine, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2011-
Fatty Liver Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2011-

List of Figures
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011-
Fatty Liver Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011-
Fatty Liver Disease Therapeutics Clinical Trials, BRIC Countries (%), 2011-
Fatty Liver Disease Therapeutics Clinical Trials, G7 Countries (%), 2011-
Fatty Liver Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, E7 Countries (%), 2011-
Fatty Liver Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011-
Fatty Liver Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Fatty Liver Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011-
Fatty Liver Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011-
Methodology

Customers who bought this item also bought

• Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
• Clinical Trial Management Systems (CTMS) - Global Strategic Business Report
• PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
• 2012 Good Clinical Practice: A Question & Answer Reference Guide
• Cellular Therapy and Cord Blood 2013 Market Report
• Healthcare Contract Research Outsourcing Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
• Clinical Trial Management Systems (CTMS) Market: Global Trends, Opportunities, Challenge and Forecasts (2011 – 2016)
• Medical Nutrition - A Global Market Overview
• ADME-Toxicology Testing - Global Strategic Business Report
• Multiple Myeloma Therapeutics - Global Strategic Business Report